首页> 外文OA文献 >Facile scalable synthesis of highly monodisperse small silica nanoparticles using alkaline buffer solution and their application for efficient sentinel lymph node mapping
【2h】

Facile scalable synthesis of highly monodisperse small silica nanoparticles using alkaline buffer solution and their application for efficient sentinel lymph node mapping

机译:使用碱性缓冲溶液可轻松扩展的高度单分散性小二氧化硅纳米粒子的合成及其在有效前哨淋巴结定位中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer nanomedicine involving nanotechnology-based drugs and in vivo imaging agents is an active field of nanoscience that provides new ways of enhancing therapeutic and diagnostic efficacy. Translating cancer nanomedicine mainly comes from rational and scalable design of nanoparticles to achieve versatile properties including specific size because nanomaterials whose properties confer unique advantages can only optimize clinical impact. Here, a facile scalable synthesis of highly monodisperse small silica nanoparticles was developed by screening various alkaline buffer solutions as catalysts. The size of silica nanoparticles ranging from 7 to 30 nm was finely controlled by varying the reaction temperature. Moderate sized silica nanoparticles in the range of 30 to 50 nm and large sized silica nanoparticles (>100 nm) were readily synthesized by in situ adding tetraethylorthosilicate (TEOS) and applying the Stöber method in the reaction solution using small silica nanoparticles as the seeds, respectively. Having shown the ability to precisely synthesize size controlled silica nanoparticles with a process compatible with good manufacturing practices, we performed in vivo fluorescence imaging and immunofluorescence analysis of sentinel lymph nodes (SLNs) with the synthesized nanoparticles having different sizes to investigate the size effect for effective identification of SLNs. The synthesized nanoparticles with a diameter of 12 nm showed effective SLN uptake within 10 min after intradermal injection both in noninvasive and in intraoperative imaging mode and were localized evenly inside the SLN, whereas the 120 nm sized nanoparticles failed to identify the SLN with noninvasive imaging at 10 min post-injection and distributed only in the medulla region not in the superficial cortex of the SLN. Taken together, a new facile scalable synthesis technique to achieve fine size controlling capability from very small silica nanoparticles (7 nm) was developed and it made possible to investigate the optimal size of nanoparticles for efficient SLN mapping which is still controversial.
机译:涉及基于纳米技术的药物和体内显像剂的癌症纳米医学是纳米科学的活跃领域,它提供了增强治疗和诊断功效的新方法。癌症纳米医学的转化主要来自纳米颗粒的合理且可扩展的设计,以实现包括特定尺寸在内的多种特性,因为具有独特优势的纳米材料只能优化临床效果。在此,通过筛选各种碱性缓冲溶液作为催化剂,开发了一种高度可扩展的高度单分散的小二氧化硅纳米颗粒的合成方法。通过改变反应温度来精细控制二氧化硅纳米颗粒的尺寸为7至30nm。通过在原位添加原硅酸四乙酯(TEOS)并在反应溶液中使用小二氧化硅纳米粒子作为种子的Stöber方法,可以轻松合成30至50 nm范围内的中型二氧化硅纳米粒子和大型二氧化硅纳米粒子(> 100 nm),分别。在显示出能够以与良好生产规范兼容的方法精确合成尺寸受控的二氧化硅纳米颗粒的能力后,我们对前哨淋巴结(SLN)进行了体内荧光成像和免疫荧光分析,并使用了具有不同尺寸的合成纳米颗粒,以研究有效的尺寸效应SLN的标识。直径为12 nm的合成纳米颗粒在皮内注射后10分钟内以无创和术中成像模式均显示出有效的SLN吸收,并且均匀分布在SLN内,而120 nm大小的纳米颗粒无法通过无创成像在注射后10分钟,仅分布在髓质区域而不是SLN的浅层皮质。综上所述,开发了一种新的简便可扩展的合成技术,该技术可从非常小的二氧化硅纳米颗粒(7 nm)实现精细的尺寸控制能力,这使得研究有效的SLN映射的纳米颗粒的最佳尺寸成为可能,这仍然是有争议的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号